Award
NIH Reporter #1K99AI192939-01A1
Transcriptional Regulation of Immune-acting Fibroblasts
Recipient
Dr. Kellen Cavagnero at UC San Diego
Award Amount
$184,520.00
Ceiling
$184,520.00
Awarded
August 06, 2026
Identifier
1K99AI192939-01A1
NIH awarded a grant to Dr. Kellen Cavagnero at UC San Diego for research on transcriptional regulation of immune-acting fibroblasts to develop therapies for skin infections and inflammatory diseases, with a $184,520 award for fiscal year 2026.
Description
This NIH grant supports research on the transcriptional regulation of dermal immune-acting fibroblasts involved in type 17 inflammation, with a focus on developing new therapies for skin infections and inflammatory diseases. The project is led by Dr. Kellen Cavagnero at UC San Diego, with a total award amount of $184,520 for the fiscal year 2026. The project involves extensive training in epigenetics, biochemistry, bioinformatics, and dermatology, and aims to define the transcription factor networks involved in fibroblast responses to IL-17 and TNF.